Elekta collaborates with leading New York cancer center to continue development of clinical protocols for MR-linac technology
STOCKHOLM, February 27, 2018 – Elekta (EKTA-B.ST) has entered into a research agreement with Memorial Sloan Kettering Cancer Center (MSK), a world leader in patient care, research and education programs, located in New York City, through which MSK will use an MR-linac system to investigate new treatment standards, imaging protocols, and treatment planning methodologies across various cancer indications. The Elekta MR-linac system is groundbreaking because it overcomes the technical barriers that have hindered the integration of radiation therapy with real-time high-field 1.5 Tesla (T) MR